McGill-Vargas Lisa L, Johnson-Pais Teresa, Johnson Marney C, Blanco Cynthia L
Department of Pediatrics, Division of Neonatology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
Department of Pediatrics, Division of Child Neurology, Developmental Pediatrics & Genetics, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
Physiol Rep. 2014 Dec 18;2(12). doi: 10.14814/phy2.12243. Print 2014 Dec 1.
Aberrant glucose regulation is common in preterm and full-term neonates leading to short and long-term morbidity/mortality; however, glucose metabolism in this population is understudied. The aim of this study was to investigate developmental differences in hepatic gluconeogenic pathways in fetal/newborn baboons. Fifteen fetal baboons were delivered at 125 day (d) gestational age (GA), 140d GA, and 175d GA (term = 185d GA) via cesarean section and sacrificed at birth. Term and healthy adult baboons were used as controls. Protein content and gene expression of key hepatic gluconeogenic molecules were measured: cytosolic and mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-C and PEPCK-M), glucose-6-phosphatase-alpha (G6Pase-α), G6Pase-β, fructose-1,6-bisphosphatase (FBPase), and forkhead box-O1 (FOXO1). Protein content of PEPCK-M increased with advancing gestation in fetal baboons (9.6 fold increase from 125d GA to 175d GA, P < 0.001). PEPCK-C gene expression was consistent with these developmental differences. Phosphorylation of FOXO1 was significantly lower in preterm fetal baboons compared to adults, and gene expression of FOXO1 was lower in all neonates when compared to adults (10% and 62% of adults respectively, P < 0.05). The FOXO1 target gene G6Pase expression was higher in preterm animals compared to term animals. No significant differences were found in G6Pase-α, G6Pase-β, FOXO1, and FBPase during fetal development. In conclusion, significant developmental differences are found in hepatic gluconeogenic molecules in fetal and neonatal baboons, which may impact the responses to insulin during the neonatal period. Further studies under insulin-stimulated conditions are required to understand the physiologic impact of these maturational differences.
异常的葡萄糖调节在早产儿和足月儿中很常见,会导致短期和长期的发病/死亡;然而,这一人群的葡萄糖代谢尚未得到充分研究。本研究的目的是调查胎儿/新生狒狒肝脏糖异生途径的发育差异。15只胎儿狒狒在妊娠125天(d)、140d和175d(足月=185d)时通过剖宫产分娩,并在出生时处死。足月和健康成年狒狒用作对照。测量了关键肝脏糖异生分子的蛋白质含量和基因表达:胞质和线粒体磷酸烯醇丙酮酸羧激酶(PEPCK-C和PEPCK-M)、葡萄糖-6-磷酸酶-α(G6Pase-α)、G6Pase-β、果糖-1,6-二磷酸酶(FBPase)和叉头框O1(FOXO1)。胎儿狒狒中,PEPCK-M的蛋白质含量随着妊娠进展而增加(从125d到175d增加了9.6倍,P<0.001)。PEPCK-C基因表达与这些发育差异一致。与成年狒狒相比,早产胎儿狒狒中FOXO1的磷酸化显著降低,与成年狒狒相比,所有新生儿中FOXO1的基因表达均较低(分别为成年狒狒的10%和62%,P<0.05)。与足月动物相比,早产动物中FOXO1靶基因G6Pase的表达更高。在胎儿发育过程中,G6Pase-α、G6Pase-β、FOXO1和FBPase未发现显著差异。总之,在胎儿和新生狒狒的肝脏糖异生分子中发现了显著的发育差异,这可能会影响新生儿期对胰岛素的反应。需要在胰岛素刺激条件下进行进一步研究,以了解这些成熟差异的生理影响。